Index of microvascular resistance to assess the effect of renal denervation in the treatment of resistant hypertension

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200058696

Enrollment

Unknown

Registered

2022-04-14

Start date

2022-04-01

Completion date

Unknown

Last updated

2024-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

Experimental group:Renal denervation

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged from 18 to 80 years old; 2. Patients with resistant hypertension,who have taken three or more antihypertensive drugs (including a diuretic) but have a substandard blood pressure (>140/90mmHg,1mmHg=0.133kPa); 3. Volunteer to participate in this study and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Renal artery stenosis; 2. Glomerular filtration rate<45mL/min/1.73m2; 3. Renal artery spasm or stenosis during ablation; 4. Pregnant or plan to become pregnant during the study.

Design outcomes

Primary

Measure	Time frame
Ambulatory blood pressure;Index of microvascular resistance;	—

Secondary

Measure	Time frame
Blood pressure in consulting room;Home blood pressure;	—

Countries

China

Contacts

Public ContactJunqing Gao

Shanghai Putuo District Central Hospital

kevingjq@sina.com+86 13816985971

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026